Lavipharm

Nikolaos Ladas has joined Lavipharm as our Chief Scientific Officer. Mr. Ladas brings extensive experience in scientific research and a strong commitment to compliance with medical and regulatory standards. Welcome onboard, Nikos! #Lavipharm #Strategy #Leadership #Management #Innovation #Growth #Teamwork

Congratulations Eleana Nikolopoulou!

As our newly appointed Deputy Chief Executive Officer and a recent addition to our Board of Directors, Panagiotis Giannouleas expressed his commitment to driving Lavipharm's strategic initiatives and achieving our ambitious goals. #Lavipharm #Strategy #Leadership #Management #Innovation #Growth #Teamwork

Following Algon’s two Best in Pharmacy GOLD awards for a marketing campaign, Ilias Konstantopoulos, Director of Marketing & Sales CHC at Lavipharm Hellas, proudly stated: “This recognition validates our marketing strategy. From the outset, our aim was to break away from conventional messaging, by implementing a truly novel approach. A big thank you to LamaDDB for their outstanding partnership.” Algon and go on! #Algon #Lavipharm #BestinPharmacyAwards #GoldAward #teamwork #innovation

We are thrilled to announce that Lavipharm had a successful exhibition at the annual CPHI congress held this year in Milan. Our booth was a hub of innovation and meaningful discussions, where we had the chance to connect with industry leaders, showcase our cutting-edge solutions, and explore new opportunities for collaboration. A huge thank you to everyone who visited us and engaged in inspiring conversations. Your enthusiasm and insights drive us to keep pushing the boundaries of pharmaceutical excellence. Looking forward to continuing our journey together and making a positive impact on global healthcare! Congrats to our team! #CPHI2024 #Lavipharm #Pharmaceuticals #Innovation #Healthcare #CPhIWorldwide #CPhIMilan Telemaque Lavidas, Katerina Tsardaka, Ioannis Sarigiannidis, Nikolaos Ladas, Ligia Panaitescu, Roxani Skartsiouni, Alex Tsitomeneas, Vassia Regkli, Christos Kostis, Petroula Batzakaki, Maria Doudesi, Anastasia Nikopoulou

We are pleased to be part of an extraordinary event that blends culture and charity—the "Zorba the Greek Ballet". Organized by the #ThyateiraUnion and #AmbrosiaCapital, this iconic ballet will grace the stage on October 9, 2024, paying tribute to the legendary Mikis Theodorakis. The evening is dedicated to causes that deeply resonate with us: supporting initiatives in combating poverty and illiteracy, and aiding #FLOGA, an organization providing vital assistance to children battling neoplastic diseases. Join us in making a meaningful difference. Together, we care! #Lavipharm #ZorbaTheGreek #Charity #CulturalHeritage #MikisTheodorakis

Lavipharm has solidified its position as a dynamic and forward-looking company. As our CEO, Telemaque Lavidas, highlighted in Η ΝΑΥΤΕΜΠΟΡΙΚΗ | NAFTEMPORIKI's "Leaders" Special Edition, the company has not only reemerged with a rich history but has also demonstrated significant growth and innovation in recent years.   "2022 and 2023 were particularly successful years for Lavipharm", stressed Mr. Lavidas. "We exceeded our annual targets for both sales and EBITDA, demonstrating our ability to deliver consistent performance. In early 2024, we achieved key milestones, including the acquisition of established products and a strategic entry into the medical cannabis market.   To support this growth trajectory, we have recently announced a new organizational structure at our Annual Shareholders' Meeting. This structural change marks a significant milestone for Lavipharm, positioning us for continued success and expansion.“   #Lavipharm #Naftemporiki #Strategy #Leaders

We are excited to announce our participation in CPhI 2024, taking place this year in Milan, from 8 to 10 October. CPhI is one of the world's premier pharmaceutical industry events. At booth 16A40, our team will showcase our pharmaceutical technologies and product portfolio, highlighting our commitment to innovation, quality and reliability. Join us to explore new opportunities together. We look forward to seeing you at CPHI 2024! #CPHI2024 #Lavipharm #Pharmaceuticals #Innovation #Healthcare #CPhIWorldwide #Milan

We are pleased to announce our financial results for the first half of 2024, reflecting steady growth and continued upward performance across our operations.   For key financial highlights, please read our press release here: https://lnkd.in/dkyEsq9Z #Lavipharm #H12024Results #FinancialPerformance #Growth #Innovation

We are proud to continue our longstanding support for MDA Hellas. This year, we are excited to sponsor the upcoming concert on September 18, 2024, at 9:00 PM at the Veakeio Theater in Piraeus. Proceeds will help expand the 'Home Support' program for people living with Amyotrophic Lateral Sclerosis (ALS). Join us in making a difference. Together, we care! #Lavipharm #MDAHellas #Concert #DimitraGalani #PavlinaVoulgaraki #VeakeioTheater